vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and ZIONS BANCORPORATION, NATIONAL ASSOCIATION (ZION). Click either name above to swap in a different company.
ZIONS BANCORPORATION, NATIONAL ASSOCIATION is the larger business by last-quarter revenue ($891.0M vs $493.8M, roughly 1.8× Pediatrix Medical Group, Inc.). ZIONS BANCORPORATION, NATIONAL ASSOCIATION runs the higher net margin — 29.5% vs 6.8%, a 22.7% gap on every dollar of revenue. On growth, ZIONS BANCORPORATION, NATIONAL ASSOCIATION posted the faster year-over-year revenue change (8.7% vs -1.7%). Over the past eight quarters, ZIONS BANCORPORATION, NATIONAL ASSOCIATION's revenue compounded faster (9.6% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Zions Bancorporation is an American national bank headquartered in Salt Lake City, Utah. It operates as a national bank rather than as a bank holding company and does business under the following seven brands: Zions Bank, Amegy Bank of Texas, California Bank and Trust, National Bank of Arizona, Nevada State Bank, Vectra Bank Colorado, and the Commerce Bank of Washington.
MD vs ZION — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $891.0M |
| Net Profit | $33.7M | $263.0M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | — |
| Net Margin | 6.8% | 29.5% |
| Revenue YoY | -1.7% | 8.7% |
| Net Profit YoY | 10.5% | 21.8% |
| EPS (diluted) | $0.40 | $1.77 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $891.0M | ||
| Q3 25 | $492.9M | $861.0M | ||
| Q2 25 | $468.8M | $838.0M | ||
| Q1 25 | $458.4M | $795.0M | ||
| Q4 24 | $502.4M | $820.0M | ||
| Q3 24 | $511.2M | $792.0M | ||
| Q2 24 | $504.3M | $777.0M | ||
| Q1 24 | $495.1M | $742.0M |
| Q4 25 | $33.7M | $263.0M | ||
| Q3 25 | $71.7M | $222.0M | ||
| Q2 25 | $39.3M | $244.0M | ||
| Q1 25 | $20.7M | $170.0M | ||
| Q4 24 | $30.5M | $216.0M | ||
| Q3 24 | $19.4M | $214.0M | ||
| Q2 24 | $-153.0M | $201.0M | ||
| Q1 24 | $4.0M | $153.0M |
| Q4 25 | 9.9% | — | ||
| Q3 25 | 13.8% | — | ||
| Q2 25 | 12.8% | — | ||
| Q1 25 | 7.0% | — | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | -31.3% | — | ||
| Q1 24 | 3.2% | — |
| Q4 25 | 6.8% | 29.5% | ||
| Q3 25 | 14.5% | 25.8% | ||
| Q2 25 | 8.4% | 29.1% | ||
| Q1 25 | 4.5% | 21.4% | ||
| Q4 24 | 6.1% | 26.3% | ||
| Q3 24 | 3.8% | 27.0% | ||
| Q2 24 | -30.3% | 25.9% | ||
| Q1 24 | 0.8% | 20.6% |
| Q4 25 | $0.40 | $1.77 | ||
| Q3 25 | $0.84 | $1.48 | ||
| Q2 25 | $0.46 | $1.63 | ||
| Q1 25 | $0.24 | $1.13 | ||
| Q4 24 | $0.37 | $1.34 | ||
| Q3 24 | $0.23 | $1.37 | ||
| Q2 24 | $-1.84 | $1.28 | ||
| Q1 24 | $0.05 | $0.96 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | — |
| Total DebtLower is stronger | $570.5M | $1.5B |
| Stockholders' EquityBook value | $865.9M | $7.2B |
| Total Assets | $2.2B | $89.0B |
| Debt / EquityLower = less leverage | 0.66× | 0.21× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | — | ||
| Q3 25 | $340.1M | — | ||
| Q2 25 | $224.7M | — | ||
| Q1 25 | $99.0M | — | ||
| Q4 24 | $229.9M | — | ||
| Q3 24 | $103.8M | — | ||
| Q2 24 | $19.4M | — | ||
| Q1 24 | $8.0M | — |
| Q4 25 | $570.5M | $1.5B | ||
| Q3 25 | $577.2M | $1.5B | ||
| Q2 25 | $583.9M | $970.0M | ||
| Q1 25 | $590.5M | $964.0M | ||
| Q4 24 | $597.1M | $950.0M | ||
| Q3 24 | — | $548.0M | ||
| Q2 24 | — | $546.0M | ||
| Q1 24 | — | $544.0M |
| Q4 25 | $865.9M | $7.2B | ||
| Q3 25 | $890.7M | $6.9B | ||
| Q2 25 | $833.8M | $6.6B | ||
| Q1 25 | $789.2M | $6.3B | ||
| Q4 24 | $764.9M | $6.1B | ||
| Q3 24 | $732.5M | $6.4B | ||
| Q2 24 | $706.5M | $6.0B | ||
| Q1 24 | $856.2M | $5.8B |
| Q4 25 | $2.2B | $89.0B | ||
| Q3 25 | $2.2B | $88.5B | ||
| Q2 25 | $2.1B | $88.9B | ||
| Q1 25 | $2.0B | $88.0B | ||
| Q4 24 | $2.2B | $88.8B | ||
| Q3 24 | $2.1B | $87.0B | ||
| Q2 24 | $2.0B | $87.6B | ||
| Q1 24 | $2.2B | $87.1B |
| Q4 25 | 0.66× | 0.21× | ||
| Q3 25 | 0.65× | 0.21× | ||
| Q2 25 | 0.70× | 0.15× | ||
| Q1 25 | 0.75× | 0.15× | ||
| Q4 24 | 0.78× | 0.16× | ||
| Q3 24 | — | 0.09× | ||
| Q2 24 | — | 0.09× | ||
| Q1 24 | — | 0.09× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $1.1B |
| Free Cash FlowOCF − Capex | — | $952.0M |
| FCF MarginFCF / Revenue | — | 106.8% |
| Capex IntensityCapex / Revenue | — | 13.6% |
| Cash ConversionOCF / Net Profit | 3.39× | 4.08× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.4B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $1.1B | ||
| Q3 25 | $137.3M | $438.0M | ||
| Q2 25 | $137.2M | $-62.0M | ||
| Q1 25 | $-117.5M | $179.0M | ||
| Q4 24 | $133.0M | $1.1B | ||
| Q3 24 | $91.8M | $119.0M | ||
| Q2 24 | $107.0M | $251.0M | ||
| Q1 24 | $-125.2M | $261.0M |
| Q4 25 | — | $952.0M | ||
| Q3 25 | — | $413.0M | ||
| Q2 25 | — | $-93.0M | ||
| Q1 25 | — | $152.0M | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $97.0M | ||
| Q2 24 | — | $234.0M | ||
| Q1 24 | — | $231.0M |
| Q4 25 | — | 106.8% | ||
| Q3 25 | — | 48.0% | ||
| Q2 25 | — | -11.1% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 128.2% | ||
| Q3 24 | — | 12.2% | ||
| Q2 24 | — | 30.1% | ||
| Q1 24 | — | 31.1% |
| Q4 25 | — | 13.6% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 3.4% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | 4.0% |
| Q4 25 | 3.39× | 4.08× | ||
| Q3 25 | 1.91× | 1.97× | ||
| Q2 25 | 3.49× | -0.25× | ||
| Q1 25 | -5.66× | 1.05× | ||
| Q4 24 | 4.36× | 5.31× | ||
| Q3 24 | 4.72× | 0.56× | ||
| Q2 24 | — | 1.25× | ||
| Q1 24 | -31.03× | 1.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
ZION
Segment breakdown not available.
